CCS adapting to COVID-19 realities to support Canadians during and after the pandemic
Diane Gosselin has over 25 years of experience in financing innovative biomedical research. She is currently President and Chief Executive Officer of CQDM.
During her tenure at CQDM, Diane has engaged a national network of over 2000 researchers across Canada and raised over $80M in funding from 14 of the largest pharmaceutical companies in the world.
Prior to CQDM, Diane worked for the Fonds de solidarité and PROCREA BioSciences, where she led the research team that developed the first non-invasive diagnostic test for endometriosis and developed the world’s largest tissue bank for endometriosis research.
Diane currently sits on the boards of various research and science organizations.
Diane holds a Ph.D. in Microbiology and Immunology from University of Montreal, as well as an Executive MBA from Université du Québec à Montréal and Université Paris-Dauphine. More recently, she completed a university certification program in Corporate Governance from Université Laval.